Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., Hyman, B. T.·2011·Cold Spring Harbor Perspectives in Medicine

Cited by (1,028)

Items 901–1,000 of 1,028

  1. Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
    Takatori, Sho, Wang, Wenbo, Iguchi, Akihiro, Tomita, Taisuke · 2019 · Advances in Experimental Medicine and Biology
  2. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
    Finze, Anika, Biechele, Gloria, Rauchmann, Boris-Stephan, Franzmeier, Nicolai, Palleis, Carla, Katzdobler, Sabrina, Weidinger, Endy, Guersel, Selim, Schuster, Sebastian, Harris, Stefanie et al. · 2023 · Molecular Psychiatry
  3. Distinct transcriptomic responses to Aβ plaques, neurofibrillary tangles, and <i>APOE</i> in Alzheimer's disease
    Das, Sudeshna, Li, Zhaozhi, Wachter, Astrid, Alla, Srinija, Noori, Ayush, Abdourahman, Aicha, Tamm, Joseph A., Woodbury, Maya E., Talanian, Robert V., Biber, Knut et al. · 2024 · Alzheimer's &amp; Dementia
  4. Neuropathology in chronic traumatic encephalopathy: a systematic review of comparative post-mortem histology literature
    Helen C. Murray, Chelsie Osterman, Paige Bell, Luca Vinnell, Maurice A. Curtis · 2022 · Acta Neuropathologica Communications
  5. Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease
    Victoria Chaoul, Emanuel‐Youssef Dib, Joe Bedran, Chakib Khoury, Omar Shmoury, Frédéric Harb, Jihane Soueid · 2023 · International Journal of Molecular Sciences
  6. Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of A lzheimer's Disease
    Nibaldo C. Inestrosa, Juvenal A. Ríos, Pedro Cisternas, Cheril Tapia‐Rojas, Daniela S. Rivera, Nady Braidy, Juan Manuel Zolezzi, Juan Alejandro Godoy, Francisco J. Carvajal, Álvaro O. Ardiles et al. · 2014 · Brain Pathology
  7. Caffeic acid phenethyl ester (CAPE) prevents development of STZ-ICV induced dementia in rats
    Nitin Bansal, Manish Kumar, Devinder Kaur · 2017 · Pharmacognosy Magazine
  8. Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer’s Disease
    Tingxiang Yan, Luwen Wang, Ju Gao, Sandra L. Siedlak, Mikayla L. Huntley, Pichet Termsarasab, George L. Perry, Shu G. Chen, Xinglong Wang · 2018 · Journal of Alzheimer s Disease
  9. Three Doses of Vitamin D and Cognitive Outcomes in Older Women: A Double-Blind Randomized Controlled Trial
    Monica Castle, Nancy L. Fiedler, L. Claudia Pop, S. Schneider, Yvette Schlussel, Deeptha Sukumar, Lihong Hao, Sue A. Shapses · 2019 · The Journals of Gerontology Series A
  10. Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease.
    Jessika Royea, P. Martinot, E. Hamel · 2020 · Neurobiology of Disease
  11. Astrocytes and Adenosine A2A Receptors: Active Players in Alzheimer’s Disease
    Cátia R. Lopes, Rodrigo Antunes Cunha, Paula M. Agostinho · 2021 · Frontiers in Neuroscience
  12. Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease
    Tooran Nayeri, Shahabeddin Sarvi, Mehdi Sharif, Ahmad Daryani · 2021 · Heliyon
  13. The role of microRNA-34 family in Alzheimer’s disease: A potential molecular link between neurodegeneration and metabolic disorders
    Maryam Bazrgar, Pariya Khodabakhsh, Mercedes Prudencio, Fatemeh Mohagheghi, Abolhassan Ahmadiani · 2021 · Pharmacological Research
  14. Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease
    Ankit Jana, Arkadyuti Bhattacharjee, Sabya Sachi Das, Avani Srivastava, Akshpita Choudhury, Rahul Bhattacharjee, Swagata De, Asma Perveen, Danish Iqbal, Piyush Kumar Gupta et al. · 2022 · Molecular Neurobiology
  15. Neuropathology of the Alzheimer's continuum: an update
    K. A. Jellinger · 2020 · Free Neuropathology
  16. Nanozyme sensor array based on manganese dioxide for the distinction between multiple amyloid β peptides and their dynamic aggregation process
    Shun Hu, Changwen Yang, Yanqing Li, Qingming Luo, Haiming Luo · 2021 · Biosensors and Bioelectronics
  17. The Role of Thyroid Dysfunction in Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Arash Salehipour, Mahsa Dolatshahi, Maryam Haghshomar, Jay Amin · 2023 · The Journal of Prevention of Alzheimer s Disease
  18. Monoclonal Antibody Therapy in Alzheimer’s Disease
    Monica Neațu, Anca Covaliu, Iulia Ioniță, Ana Jugurt, Eugenia Irene Davidescu, Bogdan Ovidiu Popescu · 2023 · Pharmaceutics
  19. Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis
    Zaida L. Almeida, Daniela C. Vaz, Rui M. M. Brito · 2024 · Molecular Neurobiology
  20. P2Y receptors in Alzheimer's disease
    Laurie Erb, Cao Chen, Deepa Ajit, Gary A. Weisman · 2014 · Biology of the Cell
  21. Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease
    Romina J. G. Gentier, Fred W. van Leeuwen · 2015 · Frontiers in Molecular Neuroscience
  22. The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases
    Cristina Carvalho, Sónia C. Correia, Susana Cardoso, Ana I. Plácido, Emanuel Candeias, Ana Isabel Duarte, Paula Isabel Moreira · 2015 · Expert Review of Neurotherapeutics
  23. Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer’s disease: a hypothesis
    Heiko Braak, Kelly Del Tredici · 2013 · Acta Neuropathologica
  24. Quantitative T2 mapping of white matter: applications for ageing and cognitive decline
    Michael J. Knight, Bryony McCann, Demitra Tsivos, Serena Dillon, Elizabeth Jane Coulthard, Risto A. Kauppinen · 2016 · Physics in Medicine and Biology
  25. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease
    Mengni Yi, Panpan Yu, Qin Lu, Herbert M. Geller, Zhihua Yu, Hongzhuan Chen · 2016 · Molecular and Cellular Neuroscience
  26. Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer’s disease
    Frances C. Quevenco, Maria Giulia Preti, Jiri M.G. Van Bergen, Jun Hua, Michael Wyss, Xu Li, Simon J. Schreiner, Stefanie C. Steininger, Rafael Meyer, Irene B. Meier et al. · 2017 · Alzheimer s Research & Therapy
  27. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease using Cerebrospinal Fluid Biomarkers in the AIBL Study
    Samantha C. Burnham, Preciosa M. Coloma, Q.-X. Li, Steven John Collins, Greg R. Savage, Simon Matthew Laws, James D. Doecke, Paul T. Maruff, Ralph Nigel Martins, David J. Ames et al. · 2019 · The Journal of Prevention of Alzheimer s Disease
  28. Protective effects of isoquercitrin on streptozotocin‐induced neurotoxicity
    Lei Chen, Peimin Feng, Anjiao Peng, Xiangmiao Qiu, Wan‐Ling Lai, Lin Zhang, Wanling Li · 2020 · Journal of Cellular and Molecular Medicine
  29. Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders
    Pankhi Vatsa, Renu Negi, Uzair Ahmad Ansari, VK Khanna, Aditya Bhushan Pant · 2021 · Molecular Neurobiology
  30. Overcoming the cellular barriers and beyond: Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriers
    Yingke Liu, Zhihe Zhao, Man Li · 2022 · Asian Journal of Pharmaceutical Sciences
  31. Artificial Intelligence Models in the Diagnosis of Adult-Onset Dementia Disorders: A Review
    Gopi Battineni, Nalini Chintalapudi, Mohammad Amran Hossain, Giuseppe Losco, Ciro Ruocco, Getu Gamo Sagaro, Enea Traini, Giulio Nittari, Francesco Amenta · 2022 · Bioengineering
  32. Dissecting Alzheimer disease in Down syndrome using mouse models
    Xun Yu Choong, Justin Tosh, Laura J. Pulford, Elizabeth Fisher · 2015 · Frontiers in Behavioral Neuroscience
  33. Utility of Autoantibodies as Biomarkers for Diagnosis and Staging of Neurodegenerative Diseases
    Cassandra A. DeMarshall, Abhirup Sarkar, Eric P. Nagele, Eric Luria Goldwaser, George A. Godsey, Nimish K. Acharya, Robert G. Nagele · 2015 · International review of neurobiology
  34. Distinguishing early and late brain aging from the Alzheimer's disease spectrum: consistent morphological patterns across independent samples
    Nhat Trung Doan, Andreas Engvig, Krystal Zaske, Karin Persson, Martina Jonette Lund, Tobias Kaufmann, Aldo Córdova‐Palomera, Dag Alnæs, Torgeir Moberget, Anne Brækhus et al. · 2017 · NeuroImage
  35. Alzheimer's disease markers in the aged sheep (Ovis aries)
    Suzanne J. Reid, Natasha E. Mckean, Kristen Henty, Erik Portelius, Kaj Blennow, Skye R. Rudiger, Christopher Simon Bawden, Renée R. Handley, Paul John Verma, Richard L. M. Faull et al. · 2017 · Neurobiology of Aging
  36. Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine “bio-oxidizable” prodrugs: Synthesis, biological evaluation and structure-activity relationship
    Rabah Azzouz, Ludovic Peauger, Vincent Gembus, Mihaela-Liliana Ţînţaş, Jana Sopková‐de Oliveira Santos, Cyril A. Papamicaël, Vincent Levacher · 2017 · European Journal of Medicinal Chemistry
  37. α-Bisabolol loaded solid lipid nanoparticles attenuates Aβ aggregation and protects Neuro-2a cells from Aβ induced neurotoxicity
    Sethuraman Sathya, Balakrishnan Shanmuganathan, Ganeshan Manirathinam, Ruckmani Kandasamy, Kasi Pandima Devi · 2018 · Journal of Molecular Liquids
  38. Thinner retinal layers are associated with changes in the visual pathway: A population‐based study
    Ünal Mutlu, M. Kamran Ikram, Gennady V. Roshchupkin, Pieter W. M. Bonnemaijer, Johanna Maria Colijn, Johannes R. Vingerling, Wiro J. Niessen, M. Arfan Ikram, Caroline C. W. Klaver, Meike Willemijn Vernooij · 2018 · Human Brain Mapping
  39. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target
    Vladislav Petyuk, Rui R. Chang, Manuel Ramirez‐Restrepo, Noam D. Beckmann, Marc Henrion, Paul Piehowski, Kuixi Zhu, Sven Wang, Jennifer Clarke, Matthew J. Huentelman et al. · 2018 · Brain
  40. Prolactin-Releasing Peptide: Physiological and Pharmacological Properties
    Veronika Pražienková, Andrea Popelová, Jaroslav Kuneš, Lenka Maletı́nská · 2019 · International Journal of Molecular Sciences
  41. iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery
    Gianluca Costamagna, Luca Andreoli, Stefania Paola Corti, Irene Faravelli · 2019 · Cells
  42. Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer’s disease (AD) risk
    Sreedevi Raman, Nicholas Brookhouser, David A. Brafman · 2020 · Neurobiology of Disease
  43. Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease
    Océane Guillemaud, Kelly Ceyzériat, Thomas Saint-Georges, Karine Cambon, Fanny Petit, Lucile Ben Haim, María-Angeles Carrillo-de Sauvage, Martine Guillermier, Suéva Bernier, Anne‐Sophie Hérard et al. · 2019 · Neurobiology of Aging
  44. PLA2G4E, a candidate gene for resilience in Alzheimer´s disease and a new target for dementia treatment
    Marta Pérez-González, Maite Mendióroz, Sara Badesso, Diego Sucunza, Miren Roldán, María Espelosin, Susana Ursúa, Rafael Luján, Mar Cuadrado‐Tejedor, Ana García‐Osta · 2020 · Progress in Neurobiology
  45. PINK1 overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer’s disease
    Xiaojuan Wang, Lin Qi, Ya-Fang Cheng, Xuefei Ji, Tianyan Chi, Peng Liu, Libo Zou · 2021 · Acta Pharmacologica Sinica
  46. Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus
    Juan José Ramos‐Rodríguez, Carmen Infante‐Garcia, Lucia Galindo-Gonzalez, Yaiza Garcia-Molina, Alfonso Maria Lechuga-Sancho, Mónica Garcı́a-Alloza · 2015 · Molecular Neurobiology
  47. Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer’s disease brain
    Qiyue Ding, Nataliia V. Shults, Brent T. Harris, Yuichiro Suzuki · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Mitochondria and Cellular Redox State on the Route from Ageing to Alzheimer's Disease
    Abate, G., Vezzoli, M., Sandri, M., Rungratanawanich, W., Memo, M., Uberti, D · 2020 · Mechanisms of Ageing and Development
  49. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice
    Mark K. Schultz, Renee C. Gentzel, Marija Usenovic, Cheryl A. Gretzula, C. Ware, Sophie Parmentier‐Batteur, Joel B. Schachter, Hatim A. Zariwala · 2018 · Neurobiology of Disease
  50. Role of piRNA biogenesis and its neuronal function in the development of neurodegenerative diseases
    Sato, Kaoru, Takayama, Ken-ichi, Inoue, Satoshi · 2023 · Frontiers in Aging Neuroscience
  51. Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
    Yanaika S. Hok‐A‐Hin, Marta del Campo, Walter A. Boiten, Erik Stoops, Melanie Vanhooren, Afina Willemina Lemstra, Wiesje M. van der Flier, Charlotte Elisabeth Teunissen · 2023 · Journal of Neuroinflammation
  52. Oral Health as a Risk Factor for Alzheimer Disease
    Sanne M. Pruntel, Barbara C. Van Munster, J.J. de Vries, Arjan Vissink, Anita Visser · 2023 · The Journal of Prevention of Alzheimer s Disease
  53. Age, sex and Alzheimer’s disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer’s patients
    Barber, Alicia J., del Genio, Carmen L., Swain, Anna Beth, Pizzi, Elizabeth M., Watson, Sarah C., Tapiavala, Vedant N., Zanazzi, George J., Gaur, Arti B. · 2024 · Alzheimer's Research &amp; Therapy
  54. The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease
    Pedro Cisternas, Carolina B. Lindsay, Paulina Liberman Salazar, Carmen Silva-Álvarez, Rocío Retamales-Ortega, Felipe G. Serrano, Carlos Pablo Vio, Nibaldo C. Inestrosa · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  55. Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
    Franc Llorens, Matthias Schmitz, Tobias Knipper, Christian Schmidt, Peter Lange, André Fischer, Péter Hermann, Inga Zerr · 2017 · Frontiers in Aging Neuroscience
  56. Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain
    Konstantinos Chiotis, Per Stenkrona, Ove Almkvist, Vladimir Stepanov, Daniel Ferreira, Ryosuke Arakawa, Akihiro Takano, Eric Westman, Andrea Varrone, Nobuyuki Okamura et al. · 2018 · European Journal of Nuclear Medicine and Molecular Imaging
  57. Imbalanced Expression of Tau and Tubulin Induces Neuronal Dysfunction in C. elegans Models of Tauopathy
    T. Miyasaka, Yuki Shinzaki, S. Yoshimura, Sawako Yoshina, E. Kage-Nakadai, S. Mitani, Y. Ihara · 2018 · Frontiers in Neuroscience
  58. Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review
    Myuri T. Ruthirakuhan, Krista L. Lanctôt, Matteo Di Scipio, Mehnaz Atiq Ahmed, Nathan Herrmann · 2018 · Alzheimer s & Dementia
  59. Erucamide from Radish Leaves Has an Inhibitory Effect Against Acetylcholinesterase and Prevents Memory Deficit Induced by Trimethyltin
    Cho Rong Kim, Hoi Suk Kim, Soo Jung Choi, Jae Kyeom Kim, Min Chul Gim, Youn‐Jung Kim, Dong-Hoon Shin · 2018 · Journal of Medicinal Food
  60. Prediction of Autopsy Verified Neuropathological Change of Alzheimer’s Disease Using Machine Learning and MRI
    Alexander Kautzky, René Seiger, Andreas Hahn, Peter A. Fischer, Wolfgang W. Krampla, Siegfried F. Kasper, Gábor Géza Kovács, Rupert R. Lanzenberger · 2018 · Frontiers in Aging Neuroscience
  61. Recent advances in stem cells therapy: A focus on cancer, Parkinson’s and Alzheimer’s
    Dalia Fleifel, Mai Atef Rahmoon, Abdelrahman AlOkda, Mostafa Nasr, Menattallah Elserafy, Sherif F. El‐Khamisy · 2018 · Journal of Genetic Engineering and Biotechnology
  62. Icariin Delays Brain Aging in Senescence-Accelerated Mouse Prone 8 (SAMP8) Model via Inhibiting Autophagy
    Fa-Ju Chen, Bo Liu, Qin Wu, Jie Liu, Yun‐Yan Xu, Shaoyu Zhou, Jingshan Shi · 2019 · Journal of Pharmacology and Experimental Therapeutics
  63. Methylglyoxal and Glyoxal as Potential Peripheral Markers for MCI Diagnosis and Their Effects on the Expression of Neurotrophic, Inflammatory and Neurodegenerative Factors in Neurons and in Neuronal Derived-Extracellular Vesicles
    Mohamed Haddad, Morgane Perrotte, Mohamed Raâfet Ben Khedher, Clément Demongin, Aurélie Y. Le Page, Tamàs Fülöp, Charles Ramassamy · 2019 · International Journal of Molecular Sciences
  64. Establishment of the concurrent experimental model of osteoporosis combined with Alzheimer's disease in rat and the dual-effects of echinacoside and acteoside from Cistanche tubulosa.
    Yi Chen, Yingqi Li, Jia-Yi Fang, Ping Li, Fei Li · 2020 · Journal of Ethnopharmacology
  65. Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
    Christiana Bjorkli, Axel Sandvig, Ioanna Sandvig · 2020 · Frontiers in Aging Neuroscience
  66. Perspective Insights to Bio-Nanomaterials for the Treatment of Neurological Disorders
    Johra Khan, Mithun Rudrapal, Eijaz Ahmed Bhat, Ahmad Ali, Mohammad A. Alaidarous, Bader Alshehri, Saeed Banawas, Randa Mohamed Ismail, Chukwuebuka Egbuna · 2021 · Frontiers in Bioengineering and Biotechnology
  67. Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer’s disease
    Muñoz-Castro, Clara, Noori, Ayush, Magdamo, Colin G., Li, Zhaozhi, Marks, Jordan D., Frosch, Matthew P., Das, Sudeshna, Hyman, Bradley T., Serrano-Pozo, Alberto · 2022 · Journal of Neuroinflammation
  68. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease
    Teresa Musumeci, Giulia Di Benedetto, Claudia Carbone, Angela Bonaccorso, Giovanni Amato, Maria José Lo Faro, Chiara Burgaletto, Giovanni Puglisi, Renato Bernardini, Giuseppina Cantarella · 2022 · Biomedicines
  69. Deubiquitinases in Neurodegeneration
    Abudu I. Bello, Rituparna Goswami, Shelby L. Brown, Kara M. Costanzo, Taylor Shores, Shefaa K. Allan, Revan Odah, Ryan D. Mohan · 2022 · Cells
  70. TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia
    Rebecca L. Winfree, Mabel Seto, Logan C. Dumitrescu, Vilas Menon, Philip L. De Jager, Yanling Wang, Julie A. Schneider, David Alan Bennett, Angela Lee Jefferson, Timothy J. Hohman · 2023 · Acta Neuropathologica
  71. Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective
    Daniele Bano, Dan Ehninger, Giacinto Bagetta · 2023 · Cell Death Discovery
  72. Challenges and Future Prospects: A Benefaction of Phytoconstituents on Molecular Targets Pertaining to Alzheimer’s Disease
    Himanshu Sharma, Phool Chandra · 2023 · International Journal of Pharmaceutical Investigation
  73. From Soluble A β to Progressive A β Aggregation: Could Prion‐Like Templated Misfolding Play a Role?
    Yvonne S. Eisele · 2013 · Brain Pathology
  74. Physiological regulation of the heat shock response by glutamine: implications for chronic low-grade inflammatory diseases in age-related conditions
    Jaqueline Santos Moreira Leite, Vínicius Fernandes Cruzat, Maurício da Silva Krause, Paulo Ivo Homem de Bittencourt · 2016 · Nutrire
  75. Physical activity and beta-amyloid pathology in Alzheimer's disease: A sound mind in a sound body
    K. Ebrahimi, Alireza Majdi, Behrouz Baghaiee, S. H. Hosseini, S. Sadigh-Eteghad · 2017 · EXCLI Journal : Experimental and Clinical Sciences
  76. Identification of KIAA0513 and Other Hub Genes Associated With Alzheimer Disease Using Weighted Gene Coexpression Network Analysis
    Min Zhu, Longfei Jia, Fangyu Li, Jianping Jia · 2020 · Frontiers in Genetics
  77. Icariin ameliorate Alzheimer’s disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis
    Yao Chen Chuang, Iat‐Kio Van, Yonghua Zhao, Youhua Xu · 2021 · Journal of Chemical Neuroanatomy
  78. The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer’s Disease
    Janine Mett · 2021 · Antioxidants
  79. HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation
    Jae‐Ho Jeong, Dong Hoon Lee, Juhyun Song · 2022 · Biomedicine & Pharmacotherapy
  80. Comparative Epidemiological Investigation of Alzheimer’s Disease and Colorectal Cancer: The Possible Role of Gastrointestinal Conditions in the Pathogenesis of AD
    Zhang, Tianlang, Han, YaRu, Wang, JianYi, Hou, Deren, Deng, Hao, Deng, Yun L., Song, Zhi · 2018 · Frontiers in Aging Neuroscience
  81. Hippocampal transcriptome-wide association study and neurobiological pathway analysis for Alzheimer’s disease
    Na-Na Liu, Jia-Yuan Xu, Huaigui Liu, Shi-Jie Zhang, Miao-Xin Li, Yao Zhou, W. Qin, Mu-Lin Li, Chun-Shui Yu · 2021 · PLoS Genetics
  82. Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease (Review)
    Shahid Bashir, Mohammad Uzair, Turki Abualait, Muhammad Moin Ud Din Arshad, Roaa A. Khallaf, Asim Niaz, Ziyad Thani, Woo‐Kyoung Yoo, Isaac Túnez, Aslı Demirtaş-Tatlıdede et al. · 2022 · Molecular Medicine Reports
  83. Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease
    Dan Pan, An Zeng, Baoyao Yang, Gangyong Lai, Bing Hu, Xiaowei Song, Tianzi Jiang, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Advanced Science
  84. Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients
    Georgy Berezhnoy, Christoph Laske, Christoph Trautwein · 2023 · Frontiers in Aging Neuroscience
  85. Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes
    Steffi De Meyer, Elena Raluca Blujdea, Jolien M. Schaeverbeke, Mariska Reinartz, Emma Susanne Luckett, Katarzyna Adamczuk, Koen Van Laere, Patrick J. Dupont, Charlotte Elisabeth Teunissen, Rik R. Vandenberghe et al. · 2023 · Brain
  86. Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease
    Yunxiao Ren, Andrew A. Pieper, Feixiong Cheng · 2025 · Neurotherapeutics
  87. Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains
    J. Satoh, Hiroko Tabunoki, T. Ishida, Yuko Saito, K. Arima · 2012 · Neuropathology and Applied Neurobiology
  88. Truncated tau deregulates synaptic markers in rat model for human tauopathy
    Santosh Jadhav, Stanislav Katina, Andrej Kováč, Zuzana Kazmerova, Michal Novák, Norbert Žilka · 2015 · Frontiers in Cellular Neuroscience
  89. Signaling pathways and posttranslational modifications of tau in Alzheimer's disease: the humanization of yeast cells
    Jürgen J. Heinisch, Roland Brandt · 2016 · Microbial Cell
  90. Alzheimer's disease: The use of contrast agents for magnetic resonance imaging to detect amyloid beta peptide inside the brain
    Milena Salerno, Diego Santo Domingo Porqueras · 2016 · Coordination Chemistry Reviews
  91. ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing Aβ impairment of insulin signaling in an Alzheimer’s disease mouse model
    Chan, Elizabeth S., Shetty, Mahesh Shivarama, Sajikumar, Sreedharan, Chen, Christopher, Soong, Tuck Wah, Wong, Boon-Seng · 2016 · Scientific Reports
  92. A dual brain-targeting curcumin-loaded polymersomes ameliorated cognitive dysfunction in intrahippocampal amyloid-β1–42-injected mice
    Yanqiang Zhong, Tingting Jia, Zhiguo Sun, Ying Lü, Jie Gao, Hao Zou, Fangyuan Xie, Hao Xu, Du‐Xin Sun, Yu Jing Yuan et al. · 2016 · International Journal of Nanomedicine
  93. α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects
    Simona Daniele, Deborah Pietrobono, Jonathan Fusi, Caterina Iofrida, Lucia Chico, Lucia Petrozzi, Annalisa Lo Gerfo, Filippo Baldacci, Fabio Galetta, Gabriele Siciliano et al. · 2017 · Molecular Neurobiology
  94. Amyloid β Fibril Elongation by Monomers Involves Disorder at the Tip
    Marco Bacci, Jiří Vymětal, Maja Mihajlovic, Amedeo Caflisch, Andreas Vitalis · 2017 · Journal of Chemical Theory and Computation
  95. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes
    Carmen Infante‐Garcia, Juan José Ramos‐Rodríguez, Carmen Hierro‐Bujalance, Esperanza Ortegon, Eleanor K. Pickett, Rosemary J. Jackson, Fernando Hernandez Pacho, Tara L. Spires‐Jones, Mónica Garcı́a-Alloza · 2017 · Molecular Neurobiology
  96. Innate Immune and Fungal Model of Alzheimer’s Disease
    Bodo Parady · 2018 · Journal of Alzheimer s Disease Reports
  97. Interferon beta ameliorates cognitive dysfunction in a rat model of Alzheimer's disease: Modulation of hippocampal neurogenesis and apoptosis as underlying mechanism
    Sara Chavoshinezhad, Homa Mohseni Kouchesfahani, Abolhassan Ahmadiani, Leila Dargahi · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  98. Imaging Mass Spectrometry: A New Tool to Assess Molecular Underpinnings of Neurodegeneration
    Kevin Chen, Dodge Baluya, M. Tosun, Feng Li, M. Maletić-Savatić · 2019 · Metabolites
  99. Genus Boswellia as a new candidate for neurodegenerative disorders
    Arezoo Rajabian, H. Sadeghnia, Sahar Fanoudi, A. Hosseini · 2020 · Iranian Journal of Basic Medical Sciences
  100. Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17
    Qiong Liu, Shanshan Huang, Peng Yin, Su Yang, Jennifer J. Zhang, Liang Jing, Siying Cheng, Beisha Tang, Xiao‐Jiang Li, Yongcheng Pan et al. · 2020 · Nature Communications